Fund Holdings — Stonepine Capital Management, LLC

Total Portfolio Value:
$101.51M
Total Bought:
$36.88M
Total Sold:
$64.13M
Net Transaction:
-$27.25M
Securities
▲▼
SharesValue
Q1 2025
▲▼
Q2 2025
▲▼
Change
▲▼
Q1 2025
▲▼
Q2 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Adma Biologics Inc810,000750,000-60,000$24.3K$13.66M13.45%+$13.63M
Evolus, Inc.(EOLS)1,134,574916,500-218,074$13.65M$8.44M8.32%-$5.21M
Zevra Therapeutics, Inc.(ZVRA)650,000775,620+125,620$4.87M$6.83M6.73%+$1.96M
Verastem, Inc.(VSTM)613,0001,360,386+747,386$3.70M$5.65M5.56%+$1.95M
Indivior Plc304,000350,000+46,000$2.90M$5.16M5.08%+$2.26M
Acadia Pharmaceuticals Inc93,393225,000+131,607$185.8K$4.85M4.78%+$4.67M
Enanta Pharmaceuticals, Inc.(ENTA)590,742604,066+13,324$3.26M$4.57M4.50%+$1.31M
TELA Bio, Inc.(TELA)2,055,2252,083,762+28,537$2.51M$4.04M3.98%+$1.54M
Xoma Royalty Corporation129,813152,143+22,330$2.59M$3.83M3.78%+$1.25M
Iteos Therapeutics Inc110,000310,033+200,033$656.7K$3.09M3.04%+$2.43M
Day One Biopharmaceuticals I
COM
348,820450,000+101,180$2.77M$2.92M2.88%+$158.9K
Surrozen, Inc.(SRZN)285,782306,029+20,247$3.33M$2.74M2.70%-$596.3K
ANI Pharmaceuticals, Inc.(ANIP)48,00038,597-9,403$13.65M$2.52M2.48%-$11.13M
Ardelyx Inc0555,000+555,000$0$2.18M2.14%+$2.18M
Anika Therapeutics Inc206,639190,590-16,049$3.26M$2.02M1.99%-$1.24M
Aytu Biopharma Inc463,721812,676+348,955$795.0K$1.77M1.75%+$976.6K
Inhibikase Therapeutics, Inc.(IKT)914,973733,793-181,180$2.00M$1.43M1.41%-$572.9K
Geron Corporation(GERN)500,0001,000,000+500,000$795.0K$1.41M1.39%+$615.0K
Heron Therapeutics, Inc.(HRTX)796,100657,380-138,720$1.75M$1.36M1.34%-$390.6K
Nektar Therapeutics(NKTR)050,200+50,200$0$1.30M1.28%+$1.30M
Y-Mabs Therapeutics Inc131,160285,300+154,140$581.0K$1.29M1.27%+$705.7K
Collegium Pharmaceutical, Inc.(COLL)20,60741,500+20,893$615.1K$1.23M1.21%+$612.0K
Vanda Pharmaceuticals Inc.(VNDA)35,148250,000+214,852$161.3K$1.18M1.16%+$1.02M
Kalvista Pharmaceuticals Inc21,550100,000+78,450$248.7K$1.13M1.11%+$881.8K
Alumis Inc0349,615+349,615$0$1.05M1.03%+$1.05M
Myomo, Inc.(MYO)276,707457,419+180,712$1.33M$988.0K0.97%-$342.9K
Rezolute, Inc.(RZLT)0219,000+219,000$0$976.7K0.96%+$976.7K
Xeris Biopharma Holdings Inc102,265205,100+102,835$561.4K$957.8K0.94%+$396.4K
PMV Pharmaceuticals, Inc.(PMVP)630,183845,968+215,785$686.9K$896.7K0.88%+$209.8K
Syndax Pharmaceuticals, Inc.(SNDX)092,900+92,900$0$870.0K0.86%+$870.0K
Grace Therapeutics, Inc.(GRCE)294,550292,500-2,050$665.7K$868.7K0.86%+$203.0K
Kezar Life Sciences Inc
COM NEW
100,000169,859+69,859$488.0K$778.0K0.77%+$290.0K
AngioDynamics, Inc.(ANGO)077,141+77,141$0$765.2K0.75%+$765.2K
Achieve Life Sciences Inc0333,333+333,333$0$753.3K0.74%+$753.3K
Aclaris Therapeutics, Inc.(ACRS)527,842491,300-36,542$2.77M$697.6K0.69%-$2.07M
Vir Biotechnology, Inc.(VIR)144,628130,000-14,628$937.2K$655.2K0.65%-$282.0K
BioAge Labs, Inc.(BIOA)50,000151,085+101,085$188.0K$624.0K0.61%+$436.0K
Liquidia Corporation(LQDA)050,000+50,000$0$623.0K0.61%+$623.0K
An2 Therapeutics Inc0544,494+544,494$0$577.2K0.57%+$577.2K
Kiora Pharmaceuticals, Inc.(KPRX)200,647178,000-22,647$603.9K$512.6K0.51%-$91.3K
Spero Therapeutics, Inc.(SPRO)0156,888+156,888$0$455.0K0.45%+$455.0K
Hillevax Inc238,950226,009-12,941$346.5K$449.8K0.44%+$103.3K
Theratechnologies Inc25,825189,051+163,226$36.2K$446.2K0.44%+$410.0K
Pulmonx Corporation(LUNG)0145,900+145,900$0$377.9K0.37%+$377.9K
Health Catalyst, Inc.(HCAT)0100,000+100,000$0$377.0K0.37%+$377.0K
Establishment Labs Holdings Inc.(ESTA)74,5007,000-67,500$3.04M$299.0K0.29%-$2.74M
Dynavax Technologies Corp030,000+30,000$0$297.6K0.29%+$297.6K
Abeona Therapeutics Inc.(ABEO)045,000+45,000$0$255.6K0.25%+$255.6K
Savara Inc.(SVRA)29,07985,000+55,921$80.5K$193.8K0.19%+$113.3K
In8bio Inc082,430+82,430$0$172.3K0.17%+$172.3K
Nuvation Bio Inc.CL A(NUVB)085,300+85,300$0$166.3K0.16%+$166.3K
Kura Oncology, Inc.(KURA)025,000+25,000$0$144.3K0.14%+$144.3K
Climb Bio, Inc.(CLYM)0116,147+116,147$0$144.0K0.14%+$144.0K
CalciMedica, Inc.(CALC)367,37185,000-282,371$615.1K$136.0K0.13%-$479.1K
Monte Rosa Therapeutics, Inc.(GLUE)030,000+30,000$0$135.3K0.13%+$135.3K
Zentalis Pharmaceuticals, Inc.(ZNTL)60,000109,010+49,010$95.4K$126.5K0.12%+$31.1K
Boundless Bio, Inc.(BOLD)0106,175+106,175$0$107.2K0.11%+$107.2K
Coherus Oncology, Inc.(CHRS)620,58862,700-557,888$500.8K$45.9K0.05%-$455.0K
Acelyrin Inc167,5800-167,580$413.9K$0—-$413.9K
Adicet Bio Inc508,2660-508,266$203.5K$0—-$203.5K
Amarin Corp PlcADR651,6140-651,614$105.0K$0—-$105.0K
Aprea Therapeutics, Inc.(APRE)102,2420-102,242$14.4K$0—-$14.4K
Aquestive Therapeutics Inc200,0000-200,000$3.04M$0—-$3.04M
Cargo Therapeutics Inc50,0000-50,000$203.5K$0—-$203.5K
Corbus Pharmaceuticals Holdings, Inc.(CRBP)35,0000-35,000$185.8K$0—-$185.8K
Edesa Biotech, Inc.(EDSA)687,5000-687,500$1.68M$0—-$1.68M
Elanco Animal Health Incorporated(ELAN)10,0000-10,000$105.0K$0—-$105.0K
Emergent BioSolutions Inc.(EBS)5,0000-5,000$24.3K$0—-$24.3K
Esperion Therapeutics Inc Ne10,0000-10,000$14.4K$0—-$14.4K
Exagen Inc.(XGN)95,7470-95,747$343.7K$0—-$343.7K
Lakefront Biotherapeutics NVADR(LKFT)93,9680-93,968$2.36M$0—-$2.36M
NovaBridge BiosciencesADS(NBP)483,6470-483,647$398.5K$0—-$398.5K
Inovio Pharmaceuticals, Inc.(INO)518,3310-518,331$844.9K$0—-$844.9K
Iovance Biotherapeutics, Inc.(IOVA)20,0000-20,000$66.6K$0—-$66.6K
Keros Therapeutics, Inc.(KROS)100,0000-100,000$1.02M$0—-$1.02M
Milestone Pharmaceuticals Inc.(MIST)250,0000-250,000$200.0K$0—-$200.0K
Nkarta, Inc.(NKTX)10,0000-10,000$18.4K$0—-$18.4K
Optinose Inc788,6470-788,647$7.23M$0—-$7.23M
PolyPid Ltd.(PYPD)54,9750-54,975$149.0K$0—-$149.0K
Profound Medical Corp.(PROF)139,9420-139,942$814.5K$0—-$814.5K
RenovoRx, Inc.(RNXT)278,1880-278,188$275.4K$0—-$275.4K
Scpharmaceuticals Inc347,6870-347,687$914.4K$0—-$914.4K
Septerna, Inc.(SEPN)68,0840-68,084$394.2K$0—-$394.2K
Third Harmonic Bio Inc212,7830-212,783$738.4K$0—-$738.4K
UroGen Pharma Ltd.(URGN)333,4000-333,400$3.69M$0—-$3.69M
Whitehawk Therapeutics, Inc.(WHWK)46,6980-46,698$83.1K$0—-$83.1K
Page 1 of 1
Stonepine Capital Management, LLC — 13F Holdings — Q2 2025 | TickerTrail